The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
926736310 9267363 10 F 1995 20160913 20130502 20160921 EXP US-ASTRAZENECA-2011SE68502 ASTRAZENECA 81.00 YR F Y 56.20000 KG 20160921 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
926736310 9267363 1 PS ARIMIDEX ANASTROZOLE 1 Oral 20541 TABLET
926736310 9267363 2 SS ARIMIDEX ANASTROZOLE 1 Oral 20541 TABLET
926736310 9267363 3 SS ARIMIDEX ANASTROZOLE 1 Unknown GENERIC 20541
926736310 9267363 4 SS ARIMIDEX ANASTROZOLE 1 Oral 20541 1 MG TABLET QD
926736310 9267363 5 SS ARIMIDEX ANASTROZOLE 1 Oral 20541 1 MG TABLET QD
926736310 9267363 6 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U 0
926736310 9267363 7 SS TAMOXIFEN TAMOXIFEN 1 Oral Y U 0 TABLET
926736310 9267363 8 C AREDIA PAMIDRONATE DISODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
926736310 9267363 1 Breast cancer female
926736310 9267363 2 Breast cancer female
926736310 9267363 3 Breast cancer female
926736310 9267363 4 Breast cancer female
926736310 9267363 5 Breast cancer female
926736310 9267363 7 Recurrent cancer

Outcome of event

Event ID CASEID OUTC COD
926736310 9267363 HO
926736310 9267363 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
926736310 9267363 Anxiety
926736310 9267363 Asthenia
926736310 9267363 Autoimmune haemolytic anaemia
926736310 9267363 Blood bilirubin increased
926736310 9267363 Blood test abnormal
926736310 9267363 Body height decreased
926736310 9267363 Brucellosis
926736310 9267363 Carbohydrate antigen 27.29 increased
926736310 9267363 Carcinoembryonic antigen increased
926736310 9267363 Drug dose omission
926736310 9267363 Dyspnoea
926736310 9267363 Fatigue
926736310 9267363 Horner's syndrome
926736310 9267363 Lymphadenopathy
926736310 9267363 Malaise
926736310 9267363 Malignant neoplasm progression
926736310 9267363 Marrow hyperplasia
926736310 9267363 Neck pain
926736310 9267363 Pain
926736310 9267363 Peptic ulcer
926736310 9267363 Renal disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
926736310 9267363 1 1998 0
926736310 9267363 2 2007 201202 0
926736310 9267363 3 201202 0
926736310 9267363 4 2012 0
926736310 9267363 5 20160902 0
926736310 9267363 7 1998 0